$860M Lost: Singapore Construction Bleeds $2.3M Daily to WhatsApp Mayhem

TL;DR

• Sidewinder Therapeutics Raises $137M Series D for Cancer Immunotherapy Platform
• GitButler Raises $17M Series A Led by a16z to Streamline Developer Collaboration
• OnSite Raises $1.3M Seed Round to Digitize Construction Communication in Singapore

🚀 $137M Series D Propels Sidewinder’s Phase-3 Cancer Rocket Toward 2027 FDA Filing

$137M just dropped on a single cancer shot—enough to cover EVERY NFL team’s salary cap 🏈💰. That’s Sidewinder’s Series D bet that its Phase-3 solid-tumor rocket lands before 2027. If it flops, patients lose; if it wins, your cousin’s colon cancer bill could drop six figures. Ready for a post-chemo world, USA & EU?

Sidewinder Therapeutics just wired its bank account with $137 million—enough cash to finish the largest test yet of its flagship immune drug SW-201. The company is already three-quarters enrolled in the Phase 3 trial and says the first clear read on whether tumors shrink will land before New Year’s 2027.

How the platform works

SW-201 is a cell-based immunotherapy that engineers a patient’s own T-cells to hunt a panel of antigens common to lung, colon and other solid cancers. One 30-minute blood draw seeds a 12-day lab culture that yields roughly 300 million reprogrammed cells; those are frozen, shipped back and infused as a single outpatient dose.

What’s at stake

• Patients: a 30 % improvement in response rate could add 14 months of median survival for the 170,000 Americans who exhaust today’s chemo each year.
• Investors: at $135 k per treatment, 5 % market share pencils to $2.2 billion annual sales—about 4× the post-money valuation set this week.
• Competitors: Iovance, Allogene and Kymera are running rival trials; Sidewinder’s six-month head start on enrollment may compress their fundraising windows.

What could still trip it up

• Manufacturing: scaling from 30,000 to 300,000 doses a year risks a 20 % batch-failure rate seen in earlier CAR-T plants.
• Regulatory: FDA has granted Fast Track, but Breakthrough designation hinges on Q4 data beating a 35 % response hurdle—three points higher than the trial’s own target.
• Payer: CMS is piloting outcome-based rebates for cell therapies; if SW-201 misses the real-world durability mark, hospitals could face six-figure claw-backs.

Timelines to watch

• Q4 2026: top-line tumor-response data; stock volatility expected ±40 % on read-out.
• Q1 2027: pre-NDA meeting; Breakthrough tag decision.
• Q3 2028: projected U.S. launch, assuming a ten-month FDA review and no manufacturing snags.

Bottom line: Sidewinder’s Series D buys a straight shot at the first solid-tumor immunotherapy approval. Clear the 30 % response bar this December, and a single infusion could soon replace a year of chemo for as many patients as fill Fenway Park.

🛠️ $17M Series A Turbocharges GitButler to Slash Merge Mayhem

$17M just dropped to kill the pull-request headache 😱—that’s like buying every US dev a fancy keyboard just to fix Git drama. 20 yrs of Git baggage vs. 1 ex-GitHub boss with a new CLI toy 🛠️. Early adopters get merges faster than pizza delivery—will your team bite or stick to the merge-button blues?

GitButler just locked down a $17 million Series A led by a16z and shipped a public preview of its CLI and GitHub-Flow-style “GFlow” tool. The pitch is simple: after two decades of Git, merging still eats 5-15 % of a developer’s week; the startup wants that time back.

How it works

• CLI sits atop any Git repo, automating branch juggling and conflict previews.
• GFlow visualizes stacked changes so reviewers see intent, not just diffs.
• Telemetry feed lets the team tune UX every six weeks.

Early impacts

Developers: ~1,000 preview users project a 5 % cut in merge time → roughly one full day saved each month for a five-person squad.
Start-ups: faster cycle times can trim runway burn by ~$15 k per quarter for a 10-engineer company.
Incumbents: GitHub, GitLab, Azure DevOps risk feature bloat if plug-ins like GitButler prove 20 % quicker adoption.

What could go right—or wrong

• Strength: co-founder built GitHub; knows where the bodies are buried.
• Weakness: no public benchmarks yet; still a “preview” label.
• Opportunity: 10 million devs on major hosts represent a ready plug-in market.
• Threat: AI code-gen tools may leapfrog collaboration tweaks entirely.

Timelines to watch

• Q4 2026: ≥1,000 active teams; first enterprise pilots.
• Mid-2027: >5 % proven merge-time reduction triggers Series B chatter.
• 2028–29: native integration with one big host or acquisition talks; else niche.

GitButler’s success would signal that even ossified protocols like Git can be monetized one friction layer at a time—provided the stopwatch proves the pain is real.

🏗️ $860 M Lost to WhatsApp Chaos: Singapore Startup Snags $1.3 M to AI-Proof Construction Chatter

Singapore’s building sites lose $860 M a year to WhatsApp chaos 🤯—that’s $2.3 M every single day! 🏗️💸 OnSite just scooped S$1.7 M to let AI sort the multilingual mess into searchable proof. Fewer delays, happier crews. Ready to ditch the paper chase? — contractors, would you tap this on your next gig?

OnSite just locked a SGD 1.7 M seed round to prove a simple point: chatter on half-dozen apps is bleeding the island’s building sites of roughly the same taxpayer cash that could finance two new MRT stations. The startup’s AI digests voice memos, photos and text in eight local languages, then spits out a searchable audit trail in seconds—no more lost rebar photos or “forgotten” verbal change orders.

Time drain: >65 % of projects here slip because teams can’t find yesterday’s instructions → every month of delay adds ~SGD 150 k to a mid-size condo block.
Cash drain: fragmented data costs SGD 1.1 B a year, equal to 2 % of sector revenue → contractors build that waste into bids, nudging home prices upward.
Legal drain: regulators now request digital proof of safety briefings; missing chat screenshots invite fines up to SGD 50 k per incident.

Incumbents such as Procore or Fieldwire already track drawings and check-lists, but they leave multilingual chatter untouched. OnSite’s neural nets tag “beam pour delayed” in Tamil just as easily as in Mandarin, then pin the note to the exact third-floor grid line—something the big boxes still handle with manual filters.

How it actually works

1. Workers shoot a 10-second voice note.
2. OnSite’s model picks location, trade and urgency.
3. Entry is hashed for tamper-proof compliance.
4. PM queries “delay causes this week” and gets a ranked list, ready for the client meeting.

Investor angle

Tin Men Capital, Hustle Fund and Gondor Capital—three funds that rarely sit in the same cap table—each saw the same spreadsheet: a US$36–40 B regional market for construction tech, yet only US$2.5 M flowed to SEA startups last year. Owning the data layer that every rival will need to plug into looks like cheap optionality.

Outlook

• Late-2026: Beta wraps on three Singapore sites; ≥20 % drop in coordination hours should unlock a US$5–8 M Series A.
• 2027–2028: If 5 % of local projects adopt, the city could claw back SGD 550 M—enough to cover the annual power bill for 110,000 HDB flats.
• 2029: Expect at least one global incumbent (think Autodesk) to kick the tyres on an acquisition so its own dashboard can finally read Singlish voice memos.

Until then, every ghosted WhatsApp message still burns real money—SGD 30 per misplaced text, based on sector averages. OnSite’s bet is that builders will pay a few cents per log to stop that drip.

In Other News

• Injewelme Secures $1.2M Funding to Expand AI-Powered Health Monitoring in Singapore and Southeast Asia
• KreditBee Raises $280M Series E to Expand Digital Lending in Emerging Markets
• GameChange Solar Ranks #7 on TIME’s 2025 Top GreenTech Companies List
• IntelliAM Acquires RBM Lubrications for £25,000, Adding £3.32M Revenue and 7 Engineers